Idexx Laboratories (IDXX) EBT Margin (2009 - 2026)

Idexx Laboratories' EBT Margin history runs 18 years deep, the most recent figure standing at 31.16% for Q1 2026.

• In Q1 2026, EBT Margin rose 10.0% year-over-year to 31.16%; the TTM figure through Mar 2026 stood at 30.8% (up 221.0% YoY), while the FY2025 annual figure was 30.77%, up 229.0% from the prior year.
• EBT Margin was 31.16% for Q1 2026 at Idexx Laboratories, up from 28.15% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 32.66% in Q2 2025 to a low of 19.88% in Q2 2022.
• Historically, EBT Margin has averaged 28.61% across 5 years, with a median of 29.26% in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT Margin sank 1059 bps in 2022, then soared 1042 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 25.73% in 2022, then grew by 3 bps to 26.58% in 2023, then gained by 1 bps to 26.87% in 2024, then gained by 5 bps to 28.15% in 2025, then grew by 11 bps to 31.16% in 2026.
• The last three EBT Margin figures came in at 31.16% (Q1 2026), 28.15% (Q4 2025), and 31.19% (Q3 2025), per Business Quant data.